4Luisi s, Florio P,Rcis FM,et al. Inhibins in female and male rep ro2ductive physiology: role in gametogenesis,conception,implantatio-hand early pregnancy[J]. Hum Rep Rod Update,2005,11(2):123-135.
5Mariet W. Aging women with polycystic ovary syndro-mewho achieve regular menstrual cycles have a smaller follicle cohortthan those who continue to have irregular cycles[J]. Fertil Steril,2003,79(5): 1154-1160.
6Stadtmauer LA,Toma SK,Riehl RM,et al. Mefformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertiliza-tion improves outcomes and is associated with modulation of the insulin-like growth factors[J]. Fertil Steril,2001,75(3):505-509.
7Catteau-Jonard S,Pigny P,Reyss AC,et al. Changes in serum an- ti-mullerian hormone level during low-dose recombinant follieular-stimulating hormone therapy for anovulation in polyeystie ovary syndrome[J]. J Clin Endocrinol Metab,2007,92(11):4138-4143.
8Welt CK, Taylor AE, Martin KA,et al. Serum inhibin B in poly-cystic ovary syndrome: regulation by insulin and luteinizing hormone[J]. J Clin Endoerinol Metab, 2002,87 (12) : 5559-5565.
9Kowalska I, Kinalski M,Straczkowski M,et al. Insulin,leptin,IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome[J]. Eur J Endocrinol, 2001,144(5) : 509-515.
